Today, Sakura Finetek Europe, the leader in histopathology, announces the launch of its newest solution Tissue-Tek Genie, an Advanced staining system. With this groundbreaking system, the company enters a new market. By continuous 3rd-party clinical validation performed by NordiQC, Sakura Finetek provides optimal scoring antibodies only, focusing on the optimal result for pathologists and their patients.
The launch of Genie demonstrates the company’s commitment to supporting the provision of the next-generation immunohistochemistry solution. “I’m thrilled and proud with the launch of this innovative solution,” says Chris Koeman, President of Sakura Finetek Europe. “This underlines our company’s mission: empowering pathology professionals to deliver accurate and fast diagnoses to optimise treatment success for each life we touch.”
The Tissue-Tek Genie Advanced Staining System is the first and only fully automated, true random access stainer for immunohistochemistry (IHC) and in situ hybridisation (ISH); thanks to its innovative technology makes it uncompromisingly fast, providing you with a predictable case turnaround time. “This is a next-generation advanced staining system, a game changer in the complex world of advanced staining”, - Mateo Iglesias, Vice-President of Marketing and Sales, says. “Genie drives quality and standardisation of every single slide, allowing our customers to make a confident diagnostic decision with a system that will guarantee consistent and optimal results.”, Mateo concludes.
Tissue-Tek Genie is extending Sakura’s wide range of standardising pre-analytical instruments. The company has a long history of technology innovations. They launched the first fully enclosed tissue processor: Tissue-Tek VIP®, the first rapid tissue processor: Tissue-Tek Xpress® and the first automated embedding system: Tissue-Tek AutoTEC®. The Tissue-Tek Genie fits perfectly in that line and brings enormous opportunities for future innovations.
Interested histopathology and immunohistochemistry professionals can find more information on www.sakura.eu/genie or reach out to their local sales representatives.
About Sakura Finetek Europe
When it comes to diagnosing cancer, there’s no time to wait. At Sakura Finetek Europe, our drive is our desire to advance cancer diagnoses through fully automated anatomic pathology. We advance cancer diagnostics by providing integrated solutions for anatomic pathology and patients through best-in-class innovations, quality and customer care. Sakura is the original manufacturer of Tissue-Tek®, Cyto-Tek®, Tissue-Tek VIP® and Tissue-Tek Xpress®, today’s industry standards. With headquarters based in Alphen aan den Rijn (NL) and seven regional locations in Europe, we empower pathology professionals in the EMEAI region to deliver accurate and fast diagnoses to optimise treatment success for each life we touch.